We are pleased to announce that the Target ALS Annual Meeting will take place on May 6-8, 2025, at the Renaissance Boston Waterfront in Boston, MA.  

The meeting brings together members of our global Innovation Ecosystem to share scientific breakthroughs and forge collaborations that will accelerate ALS drug development. Since our founding in 2013, the gathering has emerged as one of the premier ALS research conferences in the world, with representatives from academia, pharma/biotech companies, venture capital firms, and nonprofit organizations in attendance. The meeting features a plenary session with Target ALS-funded scientists sharing their latest findings in disease biology and therapeutic development, a poster session, and several opportunities to network, which can be facilitated through the Target ALS App.

 
NOTE: While in-person attendance is limited, a virtual option will be available to extend participation to the broader research community. Live streaming with virtual Q&A will be available via the Target ALS app.